Please use this identifier to cite or link to this item: http://hdl.handle.net/10311/1654
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTshitenge, Stephane-
dc.contributor.authorMandiwana, Aszhani-
dc.date.accessioned2017-05-11T07:03:56Z-
dc.date.available2017-05-11T07:03:56Z-
dc.date.issued2017-02-15-
dc.identifier.citationTshitenge, S. & Mandiwana, A. (2017) Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study. South African Family Practice, Vol. 1, No. 1, pp. 1-4en_US
dc.identifier.issnISSN 2078-6190-
dc.identifier.urihttp://hdl.handle.net/10311/1654-
dc.description.abstractBackground: About 37 million people are living with human-immunodeficiency-virus (HIV) worldwide, with 2.6 million co-infected with the hepatitis B virus (HBV). HBV infection causes 650 000 deaths annually worldwide. Botswana has a high prevalence of HIV and a growing population of patients on highly active antiretroviral therapy (HAART). This study aimed to determine the prevalence of HIV–HBV co-infection amongst HAART eligible adult patients in some rural settings in Botswana. Methods: A cross-sectional study was conducted amongst HAART eligible adult patients at 15 HAART clinics in the Mahalapye, Ngami and Serowe Health Districts of Botswana, from August to October 2015. A total of 132 were recruited; of these 118 consented and were tested for HBsAg reactivity using Elisa. Results: Six (5.1%, 6/118) patients from the three rural health districts were HIV–HBV co-infected, with three in the 20–29 age group. The association between sex and HIV–HBV co-infection status was not statistically significant; p = 1.00. Conclusion: The finding of 5.1% HIV–HBV co-infection prevalence in some rural settings of Botswana was similar to results from one study conducted in a Botswana urban centre, while another previous similar study reported prevalence as being twice as high. This finding may call for prioritisation of pre-HAART HBV screening and early HAART initiation for all HIV-infected patients.en_US
dc.language.isoenen_US
dc.publisherCogent OA, https://www.cogentoa.com/en_US
dc.subjectBotswanaen_US
dc.subjectHBsAg screeningen_US
dc.subjectHIV–HBV co-infection prevalenceen_US
dc.titlePrevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional studyen_US
dc.typePublished Articleen_US
dc.linkhttp://www.tandfonline.com/doi/full/10.1080/20786190.2016.1272230en_US
Appears in Collections:Research articles (School of Medicine)

Files in This Item:
File Description SizeFormat 
Tshitenge_SAFP_2017.pdf408.64 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.